NNNN

BEARISH

$28.84 Live

Anbio Biotechnology · NASDAQ

$6.05 52W Range $55.65

NNNN Anbio Biotechnology - Fundamental Analysis

BEARISH

Console Chart News

NNNN Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Medical Instruments & Supplies

Current Price Live

$28.84

52W High

$55.65

52W Low

$6.05

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 15, 2026

Market cap

$1.27B

P/E

192.27

ROE

27.0%

Profit margin

74.1%

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

AI-powered fundamental assessment

Confidence

95%

The company exhibits a stable Piotroski F-Score of 5/9, but this fundamental stability is completely overshadowed by an extreme valuation disconnect. With a Graham Number of $1.46 and an Intrinsic Value of $1.05, the current price of $28.84 represents a massive speculative premium. While profitability margins and revenue growth are exceptional, the Price-to-Sales ratio of 146.39 and P/E of 192.27 are unsustainable. Combined with a bearish technical trend (0/100) and weak insider sentiment, the stock appears to be in a bubble phase.

Key Strengths

Exceptional profit margins (74.06%) and gross margins (87.24%)

Strong year-over-year revenue growth of 73.90%

Extremely high liquidity with a current ratio of 344.31

Strong Return on Equity (ROE) of 27.05%

Stable operational health as indicated by a Piotroski F-Score of 5/9

Key Risks

Severe overvaluation with a P/S ratio of 146.39

Massive gap between current price ($28.84) and Graham Number ($1.46)

Bearish technical trend (0/100) suggesting a loss of momentum

Low insider sentiment (40/100) indicating lack of internal confidence

Complete lack of analyst coverage and target price guidance

AI Fair Value Estimate

Based on comprehensive analysis

$2.15

-92.5% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Moderate

Value

Future

Past

Health

Dividend

AI Verdict

Speculative Bubble

Key drivers: Extreme valuation multiples, Disconnect from intrinsic value, Bearish technicals

Confidence

90%

Value

5/100

Ref P/E, PEG, Graham Number

Positives

No standout positives identified.

Watchpoints

P/E of 192.27
P/S of 146.39
Price is ~20x the Graham Number

Future

85/100

Ref Growth rates

Positives

73.9% Revenue Growth
High operating leverage

Watchpoints

Growth must be exponential to justify current price

Past

90/100

Ref Historical trends

Positives

1Y Change of +349.9%
Strong historical price appreciation

Watchpoints

No urgent risks highlighted.

Health

65/100

Ref Altman Z-Score, Piotroski F-Score

Positives

Piotroski F-Score 5/9
Current Ratio 344.31

Watchpoints

Altman Z-Score unavailable

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

No dividend payments
0/100 Dividend Strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$28.84

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for NNNN and closest competitors.

Updated 2026-04-14

Company	5Y	3Y	1Y	6M	1M	1W
NNNN Anbio Biotechnology Primary	+399.8%	+399.8%	+349.9%	+2.7%	+32.2%	+5.4%
PHAR Pharming Group N.V. Peer	+33.8%	+54.0%	+114.2%	+20.5%	+11.9%	+2.1%
MRVI Maravai LifeSciences Holdings, Inc. Peer	-91.0%	-76.8%	+85.3%	+1.6%	+4.1%	+13.5%
BLFS BioLife Solutions, Inc. Peer	-40.8%	-0.5%	-10.7%	+10.1%	-2.1%	+1.8%
HROW Harrow, Inc. Peer	+422.2%	+56.8%	+53.0%	-4.1%	-2.7%	+1.8%

NNN

Anbio Biotechnology

Primary

+399.8%

+349.9%

+2.7%

+32.2%

+5.4%

PHA

Pharming Group N.V.

Peer

+33.8%

+54.0%

+114.2%

+20.5%

+11.9%

+2.1%

MRV

Maravai LifeSciences Holdings, Inc.

Peer

-91.0%

-76.8%

+85.3%

+1.6%

+4.1%

+13.5%

BLF

BioLife Solutions, Inc.

Peer

-40.8%

-0.5%

-10.7%

+10.1%

-2.1%

+1.8%

HRO

Harrow, Inc.

Peer

+422.2%

+56.8%

+53.0%

-4.1%

-2.7%

+1.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

192.27

N/A

45.92

146.39

145.01

N/A

$1.27B

Profitability

Profit margins and return metrics

Profit Margin 74.06%

Operating Margin 59.09%

Gross Margin 87.24%

ROE 27.05%

ROA 14.66%

Growth

Revenue and earnings growth rates

Revenue Growth +73.9%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

344.31

Strong

Quick Ratio

177.13

Excellent

Cash/Share

$0.27

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Total Assets

$0.0B

Liabilities

$0.0B

Equity

$0.0B

Debt/Equity

0.00x

Healthcare Sector Comparison

Comparing NNNN against 393 companies in the Healthcare sector (24 bullish, 129 neutral, 240 bearish)

P/E Ratio

192.27

This Stock

90.61

Sector Avg

+112.2% (Expensive)

Return on Equity (ROE)

27.05%

This Stock

-101.52%

Sector Avg

-126.6% (Below Avg)

Profit Margin

74.06%

This Stock

-12.47%

Sector Avg

-693.9% (Weaker)

Revenue Growth

73.9%

This Stock

124.21%

Sector Avg

-40.5% (Slower)

Current Ratio

344.31

This Stock

4.56

Sector Avg

+7451.2% (Stronger)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
NNNN Anbio Biotechnology	BEARISH	$1.27B	192.27	27.0%	74.1%	$28.84
PHAR Pharming Group N.V.	NEUTRAL	$1.22B	433.25	1.0%	0.8%	$17.33	Compare
MRVI Maravai LifeSciences Holdings, Inc.	NEUTRAL	$1.21B	-	-48.6%	-70.4%	$3.28	Compare
BLFS BioLife Solutions, Inc.	NEUTRAL	$1.2B	-	-5.2%	-3.2%	$24.87	Compare
HROW Harrow, Inc.	NEUTRAL	$1.34B	-	-8.5%	-1.9%	$35.93	Compare

NNNN Anbio Biotechnology

BEARISH

Mkt Cap

$1.3B

P/E

192.3

ROE

27.0%

Price

$28.84

PHAR Pharming Group N.V.

Compare with NNNN

Compare with NNNN

BLFS BioLife Solutions, Inc.

Compare with NNNN

Compare with NNNN

Past News Coverage

Recent headlines mentioning NNNN from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

NNNN

NNNN Anbio Biotechnology - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Healthcare Sector Comparison

Similar Companies

Past News Coverage

Wait — Don't Miss Out!